Cargando…
Significant random signatures reveals new biomarker for breast cancer
BACKGROUND: In 2012, Venet et al. proposed that at least in the case of breast cancer, most published signatures are not significantly more associated with outcome than randomly generated signatures. They suggested that nominal p-value is not a good estimator to show the significance of a signature....
Autores principales: | Saberi Ansar, Elnaz, Eslahchii, Changiz, Rahimi, Mahsa, Geranpayeh, Lobat, Ebrahimi, Marzieh, Aghdam, Rosa, Kerdivel, Gwenneg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842262/ https://www.ncbi.nlm.nih.gov/pubmed/31703592 http://dx.doi.org/10.1186/s12920-019-0609-1 |
Ejemplares similares
-
Down-Regulation of miR-200c and Up-Regulation of miR-30c
Target both Stemness and Metastasis Genes in Breast Cancer
por: Rahimi, Mahsa, et al.
Publicado: (2020) -
Assessment and Molecular Actions of Endocrine-Disrupting Chemicals That Interfere with Estrogen Receptor Pathways
por: Kerdivel, Gwenneg, et al.
Publicado: (2013) -
The Ability of Different Imputation Methods to Preserve the Significant Genes and Pathways in Cancer
por: Aghdam, Rosa, et al.
Publicado: (2017) -
Expression Analysis of Long Non-Coding PCAT-1in Breast Cancer
por: Sarrafzadeh, Shaghayegh, et al.
Publicado: (2017) -
Estrogenic Potency of Benzophenone UV Filters in Breast Cancer Cells: Proliferative and Transcriptional Activity Substantiated by Docking Analysis
por: Kerdivel, Gwenneg, et al.
Publicado: (2013)